Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 18;69(37):1305-1309.
doi: 10.15585/mmwr.mm6937a6.

Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020

Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020

Sonja J Olsen et al. MMWR Morb Mortal Wkly Rep. .

Abstract

After recognition of widespread community transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), by mid- to late February 2020, indicators of influenza activity began to decline in the Northern Hemisphere. These changes were attributed to both artifactual changes related to declines in routine health seeking for respiratory illness as well as real changes in influenza virus circulation because of widespread implementation of measures to mitigate transmission of SARS-CoV-2. Data from clinical laboratories in the United States indicated a 61% decrease in the number of specimens submitted (from a median of 49,696 per week during September 29, 2019-February 29, 2020, to 19,537 during March 1-May 16, 2020) and a 98% decrease in influenza activity as measured by percentage of submitted specimens testing positive (from a median of 19.34% to 0.33%). Interseasonal (i.e., summer) circulation of influenza in the United States (May 17-August 8, 2020) is currently at historical lows (median = 0.20% tests positive in 2020 versus 2.35% in 2019, 1.04% in 2018, and 2.36% in 2017). Influenza data reported to the World Health Organization's (WHO's) FluNet platform from three Southern Hemisphere countries that serve as robust sentinel sites for influenza from Oceania (Australia), South America (Chile), and Southern Africa (South Africa) showed very low influenza activity during June-August 2020, the months that constitute the typical Southern Hemisphere influenza season. In countries or jurisdictions where extensive community mitigation measures are maintained (e.g., face masks, social distancing, school closures, and teleworking), those locations might have little influenza circulation during the upcoming 2020-21 Northern Hemisphere influenza season. The use of community mitigation measures for the COVID-19 pandemic, plus influenza vaccination, are likely to be effective in reducing the incidence and impact of influenza, and some of these mitigation measures could have a role in preventing influenza in future seasons. However, given the novelty of the COVID-19 pandemic and the uncertainty of continued community mitigation measures, it is important to plan for seasonal influenza circulation in the United States this fall and winter. Influenza vaccination of all persons aged ≥6 months remains the best method for influenza prevention and is especially important this season when SARS-CoV-2 and influenza virus might cocirculate (1).

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Cheryl Cohen reports grants from Sanofi Pasteur and non-financial support from Parexel during the conduct of the study. No other potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Number of respiratory specimens tested and percentage testing positive for influenza, by year — United States, 2016–17 through 2019–20 seasons Source: FluView Interactive. https://www.cdc.gov/flu/weekly/fluviewinteractive.htm. Abbreviation: PP = percentage positive.
FIGURE 2
FIGURE 2
Number of specimens tested and percentage testing positive for influenza, by year — Australia, Chile, and South Africa, April–August (weeks 14–31), 2017–20 Source: FluNet. https://www.who.int/influenza/gisrs_laboratory/flunet/en/. Abbreviation: PP = percentage positive.

Comment in

  • Influenza control during the COVID-19 pandemic.
    Hills T, Kearns N, Kearns C, Beasley R. Hills T, et al. Lancet. 2020 Nov 21;396(10263):1633-1634. doi: 10.1016/S0140-6736(20)32166-8. Epub 2020 Oct 22. Lancet. 2020. PMID: 33228919 Free PMC article. No abstract available.

References

    1. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2020–21 influenza season. MMWR Recomm Rep 2020;69(No. RR-8). 10.15585/mmwr.rr6908a1 - DOI - PMC - PubMed
    1. Lasry A, Kidder D, Hast M, et al.; CDC Public Health Law Program; New York City Department of Health and Mental Hygiene; Louisiana Department of Health; Public Health – Seattle & King County; San Francisco COVID-19 Response Team; Alameda County Public Health Department; San Mateo County Health Department; Marin County Division of Public Health. Timing of community mitigation and changes in reported COVID-19 and community mobility—four U.S. metropolitan areas, February 26–April 1, 2020. MMWR Morb Mortal Wkly Rep 2020;69:451–7. 10.15585/mmwr.mm6915e2 - DOI - PMC - PubMed
    1. Kuo SC, Shih SM, Chien LH, Hsiung CA. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis 2020;26:1928–30. 10.3201/eid2608.201192 - DOI - PMC - PubMed
    1. Lee H, Lee H, Song K-H, et al. Impact of public health interventions on seasonal influenza activity during the SARS-CoV-2 outbreak in Korea. Clin Infect Dis 2020;ciaa672. 10.1093/cid/ciaa672 - DOI - PMC - PubMed
    1. Cowling BJ, Ali ST, Ng TWY, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health 2020;5:e279–88. 10.1016/S2468-2667(20)30090-6 - DOI - PMC - PubMed